Clinical uses for omental tissue in the central nervous System
Descripción del Articulo
Since 1978, clinical uses within the central nervous system have been found for omentum tissue, particularly in patients with ischemic conditions and/or ischemic penumbra. Omental tissue, one form of white adipose tissue (WAT), has some features that distinguish it from other WAT depots in other are...
Autor: | |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2020 |
Institución: | Colegio Médico del Perú |
Repositorio: | Acta Médica Peruana |
Lenguaje: | español |
OAI Identifier: | oai:amp.cmp.org.pe:article/1430 |
Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/1430 |
Nivel de acceso: | acceso abierto |
Materia: | Cuerpos linforeticulares Factores neurotróficos Hormonas Omento Revascularización Lymphoreticular bodies Neurotrophic factors Hormones Omentum Revascularization |
id |
REVCMP_77d7a9471f43fadf63957f6c0918ba33 |
---|---|
oai_identifier_str |
oai:amp.cmp.org.pe:article/1430 |
network_acronym_str |
REVCMP |
network_name_str |
Acta Médica Peruana |
repository_id_str |
. |
spelling |
Clinical uses for omental tissue in the central nervous SystemAplicación clínica del epiplón en el sistema nervioso centralHernando RafaelCuerpos linforeticularesFactores neurotróficosHormonasOmentoRevascularizaciónLymphoreticular bodiesNeurotrophic factorsHormonesOmentumRevascularizationSince 1978, clinical uses within the central nervous system have been found for omentum tissue, particularly in patients with ischemic conditions and/or ischemic penumbra. Omental tissue, one form of white adipose tissue (WAT), has some features that distinguish it from other WAT depots in other areas of the body. It is the best adipose tissue for developing vascular connections with surrounding tissue, and through these newly formed arterial blood vessels, nervous parenchyma may receive nutrients, oxygen, neurotransmitters, neurotrophic factors and stem cells. Moreover, the amount of adherent scar tissue in the omentalnervous system interface is minimal.Desde 1978,el epiplón tiene aplicación clínica en el sistema nervioso central, para pacientes con isquemia y/o penúmbra isquémica .El omento, una forma de presentación del tejido adiposo blanco (TAB ) tiene algunas características que la distinguen de los otros depósitos de TAB localizados en otras zonas del cuerpo. Es el mejor tejido adiposo para desarrollar conexiones vasculares con los tejidos adyacentes y a través de éstos neovasos arteriales, el parénquima nervioso recibe nutrientes, oxígeno ,neurotransmisores ,factores neurotróficos y células madre. Por otro lado, la cantidad de cicatriz adherente en la interface omento-sistema nervioso es mínimo.Colegio Médico del Perú2020-08-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1430ACTA MEDICA PERUANA; Vol. 25 No. 3 (2008); 176 - 180ACTA MEDICA PERUANA; Vol. 25 Núm. 3 (2008); 176 - 1801728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1430/880Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:amp.cmp.org.pe:article/14302023-07-06T05:50:41Z |
dc.title.none.fl_str_mv |
Clinical uses for omental tissue in the central nervous System Aplicación clínica del epiplón en el sistema nervioso central |
title |
Clinical uses for omental tissue in the central nervous System |
spellingShingle |
Clinical uses for omental tissue in the central nervous System Hernando Rafael Cuerpos linforeticulares Factores neurotróficos Hormonas Omento Revascularización Lymphoreticular bodies Neurotrophic factors Hormones Omentum Revascularization |
title_short |
Clinical uses for omental tissue in the central nervous System |
title_full |
Clinical uses for omental tissue in the central nervous System |
title_fullStr |
Clinical uses for omental tissue in the central nervous System |
title_full_unstemmed |
Clinical uses for omental tissue in the central nervous System |
title_sort |
Clinical uses for omental tissue in the central nervous System |
dc.creator.none.fl_str_mv |
Hernando Rafael |
author |
Hernando Rafael |
author_facet |
Hernando Rafael |
author_role |
author |
dc.subject.none.fl_str_mv |
Cuerpos linforeticulares Factores neurotróficos Hormonas Omento Revascularización Lymphoreticular bodies Neurotrophic factors Hormones Omentum Revascularization |
topic |
Cuerpos linforeticulares Factores neurotróficos Hormonas Omento Revascularización Lymphoreticular bodies Neurotrophic factors Hormones Omentum Revascularization |
description |
Since 1978, clinical uses within the central nervous system have been found for omentum tissue, particularly in patients with ischemic conditions and/or ischemic penumbra. Omental tissue, one form of white adipose tissue (WAT), has some features that distinguish it from other WAT depots in other areas of the body. It is the best adipose tissue for developing vascular connections with surrounding tissue, and through these newly formed arterial blood vessels, nervous parenchyma may receive nutrients, oxygen, neurotransmitters, neurotrophic factors and stem cells. Moreover, the amount of adherent scar tissue in the omentalnervous system interface is minimal. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-08-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/1430 |
url |
https://amp.cmp.org.pe/index.php/AMP/article/view/1430 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/1430/880 |
dc.rights.none.fl_str_mv |
Copyright (c) 2020 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 ACTA MEDICA PERUANA |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
publisher.none.fl_str_mv |
Colegio Médico del Perú |
dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol. 25 No. 3 (2008); 176 - 180 ACTA MEDICA PERUANA; Vol. 25 Núm. 3 (2008); 176 - 180 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
instname_str |
Colegio Médico del Perú |
instacron_str |
CMP |
institution |
CMP |
reponame_str |
Acta Médica Peruana |
collection |
Acta Médica Peruana |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1845247447188635648 |
score |
13.2911825 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).